	Association of neutrophil percentage-to-albumin ratio with distant metastasis and survival outcomes in breast cancer patients: a retrospective and prospective cohort study. Sci Rep Liu Y, Luo R, Wu Z, Zhang W, Liang C, Liu Z, Zhao H. PMID: 41310002 [PubMed - as supplied by publisher]
	PSMA-targeted PET imaging in patients with metastatic triple-negative breast cancer: results of the prospective PRISMA trial. Eur J Nucl Med Mol Imaging Manley M, Nader-Marta G, Ozturk AA, Kassas M, Rothé F, Taraji L, Sotiriou C, Wimana Z, Salgado R, Flamen P, Gebhart G. PMID: 41309999 [PubMed - as supplied by publisher]
	A Benchmark for Breast Cancer Screening and Diagnosis in Mammogram Visual Question Answering. Nat Commun Zhu J, Huang F, Luo Q, Chen H. PMID: 41309622 [PubMed - as supplied by publisher]
	A prospective trial for breast cancer diagnosis by canine odorology. Nat Commun Tardivon A, Mesurolle B, Dureau S, Poncelet E, Dravet F, Langer A, El Bejjani MR, Alran S, Deluche E, Savignoni A, Kadi A, Bauër P, Gilbert C, Leemans M, Fromantin I. PMID: 41309562 [PubMed - indexed for MEDLINE]
	Genitourinary syndrome of menopause induced by breast cancer treatments: a randomised clinical trial protocol comparing multimodal pelvic floor physiotherapy and fractional CO(2) laser therapy (PILME study). BMJ Open Torres-Lacomba M, Hernández-Iglesias CM, Del Valle-Rubido C, Navarro-Brazález B, Rangel-de la Mata P, Lorenzo-Gallego L, Sánchez-Sánchez B, Salvador-Osuna M, Lázaro-Carrasco de la Fuente J. PMID: 41309480 [PubMed - indexed for MEDLINE]
	Understanding preferences for self-sampling in a national cervical screening programme: a protocol for a discrete choice experiment. BMJ Open Thapa S, Davies JC, Crosbie EJ, Payne K, Wright S. PMID: 41309460 [PubMed - indexed for MEDLINE]
	The impact of body mass index on survival and surgical outcomes in ovarian cancer: insights from the MITO trials. Int J Gynecol Cancer Di Lauro T, De Benedictis I, Chiodini P, Perrone F, Arenare L, Raspagliesi F, Cecere SC, Palaia I, Carbone V, Di Stefano MG, Bianco R, Pisano C, Bartoletti M, Savarese A, Schettino C, Limongello D, Mormile MG, Coppola E, Pignata S. PMID: 41309411 [PubMed - as supplied by publisher]
	Correspondence on "Survival impact and prognostic factors of secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: a systematic review and trial-level meta-analysis" by Kim et al. Int J Gynecol Cancer Wang L, Gao F, Wu Q. PMID: 41309410 [PubMed - as supplied by publisher]
	Uterine mesenchymal tumour with KAT6B::KANSL1 fusion: a new clinically significant diagnostic entity. Pathology Uivaa F, Song L, Kumar A, Swanepoel H, Robb T, Dorwal P. PMID: 41309347 [PubMed - as supplied by publisher]
	Radiomics-Based Machine Learning for the Detection of Myometrial Invasion in Endometrial Cancer: Systematic Review and Meta-Analysis. J Med Internet Res Jiang W, Wang H, Cui Y. PMID: 41309108 [PubMed - indexed for MEDLINE]
	Identification of lncRNA ZNF252P-AS1 as a novel diagnostic and prognostic biomarker for breast cancer patients: An integrated bioinformatics and experimental analysis. Clin Chim Acta El-Ashmawy NE, Abo-Saif MA, Hamouda SM, Khedr EG. PMID: 41308720 [PubMed - as supplied by publisher]
	The Lucerne Toolbox 3: digital health and artificial intelligence to optimise the patient journey in early breast cancer-a multidisciplinary consensus. Lancet Oncol Pfob A, Pinker K, Vaz-Luis I, Di Meglio A, Cardoso MJ, Curigliano G, Gentilini OD, Gruber G, Hauser N, Heil J, Kaidar-Person O, Knauer M, Lee HB, Lee SB, Loi S, Mannhart M, Mastora S, Meattini I, Di Micco R, Noske A, Peccatori FA, Poulakaki F, Reinisch M, Rubio IT, Swanton C, Tausch C, Vrancken Peeters MJ, Yu JH, Weber WP, Zerbe N, Poortmans P, Denkert C, Mann R, Delaloge S, Dubsky P, Toolbox 3 Consortium. PMID: 41308690 [PubMed - indexed for MEDLINE]
	Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials. Lancet Oncol Conforti F, Holtschmidt J, Nekljudova V, Sala I, Pagan E, Solbach C, Untch M, Denkert C, Bagnardi V, Pala L, Fasching PA, Schneeweiss A, Lück HJ, Viale G, De Pas T, van Mackelenbergh M, Huober J, Müller V, Link T, Karn T, Reinisch M, Marmé F, Bjelic-Radisic V, Schem C, Hartkopf A, Stickeler E, Hanusch C, Blohmer JU, Fehm T, Rhiem K, Gelber R, Loibl S. PMID: 41308675 [PubMed - indexed for MEDLINE]
	Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial. Lancet Oncol Yuan J, Bi XW, Hua X, Huang H, Cai L, Zhao L, Chen QJ, Chen XX, Wang XL, Lin Y, Zhang AQ, Zhong YY, Xu F, Huang JJ, An X, Shi YX, Wang X, Wang SS, Xue C, Yuan ZY. PMID: 41308674 [PubMed - indexed for MEDLINE]
	Fuzuloparib with or without apatinib in patients with HER2-negative metastatic breast cancer with germline BRCA1/2 mutations (FABULOUS): interim analysis of a multicentre, three-arm, open-label, randomised, phase 3 trial. Lancet Oncol Li H, Liu J, Ouyang Q, Wang S, Liu Y, Teng Y, Wang X, Cheng J, Tong Z, Sun T, Yan M, Zhou X, Li F, Nie J, Shao ZM, Ye C, Wang Y, Wu X, Li Z, Wu Y, Xiong H, Li H, Gan L, Niu Z, Zhang J, Zhang Q, Pan Y, Wu X, Zhang Y, Xie W, Xiao Y, Gao J, Zhao H, Yin Y, Qian Z, Sun S, Zhang H, Wang K, Lu J, Li Y, Wang X, Yang X, Wang Y, Wang Q, Song E. PMID: 41308673 [PubMed - indexed for MEDLINE]
	THBS1 Contributes to Chemoresistance in Ovarian Clear Cell Carcinoma via Promoting Epithelial-Mesenchymal Transition. J Gene Med Ye D, Liu Y, Cheng A, Xu D, Huo C, Zhao X, Pang SW, Huang C, Wang L, Lin S, Lu H. PMID: 41308635 [PubMed - indexed for MEDLINE]
	Timing of MRI for early treatment response prediction of chemoradiotherapy in uterine cervical cancer. Eur J Radiol Fridsten S, Hellman K, Sundin A, Nedar L. PMID: 41308571 [PubMed - as supplied by publisher]
	Synthesis and in vitro studies of doxorubicin-Cu(2+) prodrug and glucose oxidase co-encapsulated oxidized hyaluronic acid/carboxymethyl chitosan hydrogels on breast cancer cell line 4T1. Carbohydr Res Li S, Bian H, Tan Y, Li Y, Shou D, Jiang T, Kong Y. PMID: 41308478 [PubMed - as supplied by publisher]
	Efficacy of hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer: a bibliometric analysis and updated meta-analysis. Eur J Surg Oncol Wei J, Qiu Y, Ding Z, Lin T, Meng L, Zhang Z, Keranmu K, Liu X, Cai A, Li A, Chen Z, Fan LS. PMID: 41308399 [PubMed - as supplied by publisher]
	Levonorgestrel-releasing intra-uterine device alone for managing early-stage endometrial cancer and endometrial hyperplasia with atypia in patients unfit for surgery: the ENDOIUD study. Int J Gynecol Cancer Petrillo M, Degano M, Arcieri M, Bogani G, Legge F, Catena U, Cucinella G, Raimondo D, Capozzi VA, Dinoi G, La Fera E, Bruni S, Ceppi L, Lucidi A, D'Antonio F, D'Angelo E, Dessole F, Virdis G, Casadio P, Iodice R, Di Donna MC, Berretta R, Raspagliesi F, Fanfani F, Chiantera V, Seracchioli R, Driul L, Restaino S, Capobianco G, Vizzielli G, ENDOIUD group. PMID: 41308330 [PubMed - as supplied by publisher]

Articles 1 - 20 / 320782

Page 1 of 16040



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy